Whats Going On With SciSparc Shares Today?

SPRC Stock  USD 0.21  0.01  4.55%   
About 62% of Scisparc's investor base is looking to short. The analysis of the overall investor sentiment regarding Scisparc suggests that many traders are alarmed. The current market sentiment, together with Scisparc's historical and current headlines, can help investors time the market. In addition, many technical investors use Scisparc stock news signals to limit their universe of possible portfolio assets.
  
SciSparc Ltd shares are trading lower Monday. The company announced results for MitoCareX Bio with its drug discovery platform.

Read at benzinga.com
benzinga news
  

Scisparc Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Scisparc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Scisparc Fundamental Analysis

We analyze Scisparc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scisparc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scisparc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Scisparc is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Scisparc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scisparc stock to make a market-neutral strategy. Peer analysis of Scisparc could also be used in its relative valuation, which is a method of valuing Scisparc by comparing valuation metrics with similar companies.

Peers

Scisparc Related Equities

CVKDCadrenal Therapeutics,   7.35   
0%
78.0%
CTMXCytomX Therapeutics   3.92   
0%
41.0%
QNRXQuoin Pharmaceuticals   1.69   
0%
17.0%
UNCYUnicycive Therapeutics   1.47   
0%
15.0%
REVBRevelation Biosciences   1.33   
0%
14.0%
ASMBAssembly Biosciences   1.25   
0%
13.0%
HOTHHoth Therapeutics   1.20   
0%
12.0%
NUVBNuvation Bio   0.35   
0%
3.0%
CDIOCardio Diagnostics   3.23   
34.0%
0%
ZVSAZyVersa Therapeutics   3.60   
38.0%
0%
VRAXVirax Biolabs   4.83   
51.0%
0%
KPRXKiora Pharmaceuticals   8.68   
92.0%
0%
TILInstil Bio   9.39   
100.0%
0%

Complementary Tools for Scisparc Stock analysis

When running Scisparc's price analysis, check to measure Scisparc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scisparc is operating at the current time. Most of Scisparc's value examination focuses on studying past and present price action to predict the probability of Scisparc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scisparc's price. Additionally, you may evaluate how the addition of Scisparc to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world